DE68908958D1 - Peptide. - Google Patents

Peptide.

Info

Publication number
DE68908958D1
DE68908958D1 DE89110386T DE68908958T DE68908958D1 DE 68908958 D1 DE68908958 D1 DE 68908958D1 DE 89110386 T DE89110386 T DE 89110386T DE 68908958 T DE68908958 T DE 68908958T DE 68908958 D1 DE68908958 D1 DE 68908958D1
Authority
DE
Germany
Prior art keywords
peptide
antihypertensive
activity
ile
trp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89110386T
Other languages
English (en)
Other versions
DE68908958T2 (de
Inventor
Tsutomu Mimura
Yasuhiro Kohama
Mikio Nippon Suisan Satake
Yasukazu Nagase
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissui Corp
Original Assignee
Nippon Suisan Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Suisan Kaisha Ltd filed Critical Nippon Suisan Kaisha Ltd
Application granted granted Critical
Publication of DE68908958D1 publication Critical patent/DE68908958D1/de
Publication of DE68908958T2 publication Critical patent/DE68908958T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE89110386T 1988-06-10 1989-06-08 Peptide. Expired - Fee Related DE68908958T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63143258A JPH0778076B2 (ja) 1988-06-10 1988-06-10 新規ペプチド

Publications (2)

Publication Number Publication Date
DE68908958D1 true DE68908958D1 (de) 1993-10-14
DE68908958T2 DE68908958T2 (de) 1994-04-21

Family

ID=15334564

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89110386T Expired - Fee Related DE68908958T2 (de) 1988-06-10 1989-06-08 Peptide.

Country Status (7)

Country Link
US (1) US5071955A (de)
EP (1) EP0345778B1 (de)
JP (1) JPH0778076B2 (de)
AT (1) ATE94168T1 (de)
AU (1) AU617483B2 (de)
DE (1) DE68908958T2 (de)
ES (1) ES2059624T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977160A (en) * 1992-04-10 1999-11-02 Brigham And Women's Hospital, Inc. Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
WO2001068674A2 (en) * 2000-03-13 2001-09-20 Monsanto Technology Llc Preparation of recombinant proteins containing repeating units
KR100390529B1 (ko) * 2000-04-25 2003-07-04 동원산업 주식회사 참치정소로부터 핵산복합물질을 추출하는 방법 및 이방법에 의해 얻어진 핵산복합물질
KR101961921B1 (ko) * 2017-06-21 2019-03-26 제주대학교 산학협력단 넙치 유래의 항고혈압 펩타이드 및 이를 포함하는 항고혈압용 조성물

Also Published As

Publication number Publication date
US5071955A (en) 1991-12-10
EP0345778A1 (de) 1989-12-13
DE68908958T2 (de) 1994-04-21
JPH01313498A (ja) 1989-12-18
AU3617489A (en) 1989-12-14
ATE94168T1 (de) 1993-09-15
ES2059624T3 (es) 1994-11-16
JPH0778076B2 (ja) 1995-08-23
AU617483B2 (en) 1991-11-28
EP0345778B1 (de) 1993-09-08

Similar Documents

Publication Publication Date Title
DK1288224T3 (da) Terapeutiske peptidderivater
DE69723728D1 (de) Totalsynthese des amino hip analogen von didemnin a
ES2107033T3 (es) Peptidos bpc, su preparacion y su utilizacion.
ATE364079T1 (de) Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung
DE3850550D1 (de) Dipeptide, verwendbar als Pflanzenwachstumsregulatoren.
ES2081817T3 (es) Polipeptido con secuencias principales repetidas que se fijan en la celula.
BG96323A (bg) Нов полипептид и анти-нiv лекарство,получено от него
LV10108A (lv) Sunu proliferacijas inhibitori farmaceitiska kompozicija savienojumu iegusanas metode sunu proliferacijas inhibesanas panemieni
DK482185A (da) Peptider, deres fremstilling og anvendelse som laegemidler
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
ES2066755T3 (es) Derivados de aminoacidos inhibidores de renina.
ATE94168T1 (de) Peptide.
EP0121830A3 (de) Substituierte Dipeptide als Antihypertensiva
DE58903876D1 (de) Riboflavin-4'5'-cyclo-phosphorsaeureesterchlorid, dessen herstellung und verwendung zur herstellung von riboflavin-5'-phosphat (5'-fmn) bzw. dessen natriumsalz.
ATE89549T1 (de) Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
DE69834929D1 (de) Verwendung eines organspezifischen ernährungmittels
ES2077021T3 (es) Peptidos que tienen actividad inhibidora de renina, su preparacion y uso.
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
ES2099081T3 (es) Derivados de pradimicina.
HUP9601528A2 (hu) Véralvadásgátló hatású peptidszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények
TH17650EX (th) "อนุพันธ์เปปไทด์ที่ใช้รักษาโรค"(therapeutic peptide derivatives)
TH4690EX (th) สารผสมสำหรับใช้ในปาก
AU3363789A (en) Peptides

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee